We collaborate with patient advocacy platforms to promote quality medical care and services and to improve and expand educational and outreach efforts.
It is our mission to discover, develop and deliver innovative therapies that help to improve patients' quality of life.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
We are committed to helping improve the quality of life for those who use our therapies.
CSL Behring provides a wide range of treatments for people with rare or life-threatening illnesses.
Dr Ellie Karampini, a post-doctoral researcher at the Royal College of Surgeons in Ireland, has received a CSL Behring Prof H…
CSL Behring UK has become a full member of the Association of the British Pharmaceutical Industry (ABPI).
April 17 is World Haemophilia Day. The theme this year is “Access for All: Partnership, Policy, Progress”
Christian will be based at CSL Behring’s UK headquarters in Haywards Heath, West Sussex.
The Why Sit It Out? campaign has won a prestigious Communique award for excellence in communications.
Andrew Nash, CSL’s Chief Scientific Officer, is a busy man. He has his arms around 25 or 30 ongoing research projects spannin…
When you work at a leading global biotech company with more than 27,000 employees, serving patients in more than 100 countrie…
The scientist who put the ‘Behring’ into CSL Behring won the first Nobel Prize for medicine.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
